Pro Medicus (ASX:PME) Insider Acquires A$99,815.17 in Stock

Pro Medicus Limited (ASX:PME) insider Deena Shiff acquired 788 shares of the business’s stock in a transaction that occurred on Friday, February 13th. The shares were acquired at an average cost of A$126.67 per share, with a total value of A$99,815.17.

Pro Medicus Price Performance

The company has a quick ratio of 4.39, a current ratio of 5.98 and a debt-to-equity ratio of 1.10. The firm has a market cap of $29.16 billion, a PE ratio of 351.99, a P/E/G ratio of 3.87 and a beta of 0.56.

Pro Medicus Dividend Announcement

The business also recently announced a Interim dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 19th will be paid a dividend of $0.32 per share. This represents a yield of 27.0%. The ex-dividend date is Wednesday, February 25th. Pro Medicus’s dividend payout ratio is presently 56.41%.

About Pro Medicus

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.